Emary, Katherine R W
Golubchik, Tanya
Aley, Parvinder K
Ariani, Cristina V
Angus, Brian
Bibi, Sagida
Blane, Beth
Bonsall, David
Cicconi, Paola
Charlton, Sue
Clutterbuck, Elizabeth A
Collins, Andrea M
Cox, Tony
Darton, Thomas C
Dold, Christina
Douglas, Alexander D
Duncan, Christopher J A
Ewer, Katie J
Flaxman, Amy L
Faust, Saul N
Ferreira, Daniela M
Feng, Shuo
Finn, Adam
Folegatti, Pedro M
Fuskova, Michelle
Galiza, Eva
Goodman, Anna L
Green, Catherine M
Green, Christopher A
Greenland, Melanie
Hallis, Bassam
Heath, Paul T
Hay, Jodie
Hill, Helen C
Jenkin, Daniel
Kerridge, Simon
Lazarus, Rajeka
Libri, Vincenzo
Lillie, Patrick J
Ludden, Catherine
Marchevsky, Natalie G
Minassian, Angela M
McGregor, Alastair C
Mujadidi, Yama F
Phillips, Daniel J
Plested, Emma
Pollock, Katrina M
Robinson, Hannah
Smith, Andrew
Song, Rinn
Snape, Matthew D
Sutherland, Rebecca K
Thomson, Emma C
Toshner, Mark
Turner, David P J
Vekemans, Johan
Villafana, Tonya L
Williams, Christopher J
Hill, Adrian V S
Lambe, Teresa
Gilbert, Sarah C
Voysey, Merryn
Ramasamy, Maheshi N
Pollard, Andrew J
Funding for this research was provided by:
United Kingdom Department of Health and Social Care
Coalition for Epidemic Preparedness Innovations
Medical Research Council
This article is maintained by: Elsevier
Article Title: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(21)00628-0
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(21)00730-3
Content Type: article
Copyright: © 2021 The Author(s). Published by Elsevier Ltd.